社论转载：特鲁多政府终于有一个加拿大自产疫苗的方案！但要等到2022年才有

 

 

2月2日，加拿大老百姓早晨醒来发现，特魯多又在演今年（2021年）那部已经令人乏味的戏：他宣布了一项抗疫的新方案。问题是，这一新方案不仅实施得太晚，而且究竟谁要为实施新方案付账单。

 

Canadians woke up on Groundhog Day to a scene that keeps repeating itself over and over in 2021: Prime Minister Justin Trudeau announcing a new COVID-19 initiative that’s a day late and a loonie short.

 

渥太华一月曾初宣布，飞往加拿大的任何人必须新冠测试阴性才能登机，但这是早就应该实行的政策。

 

First there was Ottawa’s announcement in early January that anyone flying to Canada would have to produce a negative COVID-19 test in order to board their flight – a rule that should have been introduced long ago.

 

渥太华上周又说，飞往加拿大的人下机后要自费做新冠测试，并到酒店等待测试结果，在酒店的费用自理。如果测试结果为阴性，这些人还要在被监督的情况下在家隔离14天。这个办法不错，但渥太华已经晚了几个月才实行这一措施。

 

Then came the news last week that people flying into Canada will have to pay for COVID-19 testing on their arrival, hole up in a hotel at their expense while awaiting the results, and then do a supervised 14-day quarantine at home if they test negative. Good idea, but months too late.

 

现在，渥太华宣布已与美国制药公司Novavax达成协议，开始在还没有竣工的蒙特利尔联邦大楼里生产尚未审批的新冠疫苗。

 

And now comes the announcement that Canada has signed a deal with U.S. pharma company Novavax to start producing doses of a yet-to-be-approved COVID-19 vaccine at a yet-to-be-completed federal facility in Montreal.

分享不同信息/观点，做明智判断/决策！请点击096.ca！

 

这听起来咋那么令人耳熟？如果渥太华去年实施了刚刚实施的边境管制措施，同时伴随各省的抗疫措施，那将减少新冠在加拿大的传播。另外，如果早点实施新的边境管理措施，那将大大减少来自英国，巴西和南非的几种传染性更强的新冠病毒变种的入境。现在，这些变种已经进入加拿大。

 

It has a familiar ring to it, doesn’t it? Had Ottawa implemented its latest border controls last year, there is a good chance that, combined with provincial public-health measures, they would have reduced the spread of COVID-19 in Canada. Early border measures would also have greatly reduced the importation of several more contagious variants of the COVID-19 virus first discovered in Britain, Brazil and South Africa, which have now been imported here.

 

问题是，渥太华到上个月才采取行动，实行有效的旅行限制。特鲁多政府似乎无法解决眼前的问题，每个措施都慢一拍。

 

But Ottawa didn’t act to bring in effective travel restrictions until last month. It’s as if the Trudeau government can’t grapple with the problem in front of it, until it’s too late.

 

周二，特魯多宣布自产疫苗的情况也是如此。自产疫苗的想法是如此之晚，让人感到疫苗到手后，疫情恐怕已经结束了。当然，如果今后出现与新冠不同的疫情，自产疫苗将发挥作用，但这对目前正在流行的新冠疫情作用不大。

 

Tuesday’s vaccine announcement is the same. It comes so late in the game – it is essentially a plan to deliver vaccines after the game is supposed to be over – that it will have more of an impact on the next pandemic, should one ever occur, than on the current one.

 

从长远来说，自产疫苗不好。由于辉瑞和莫德纳的供货时间一拖再拖，加上欧盟威胁要下令疫苗出口，加拿大显然需要有自产疫苗的能力。这关系到国家安全和百姓健康。

 

That’s not to say it has no long-term value. Given the repeated delays from manufacturers Pfizer and Moderna, and the European Union’s threat to block exports, it’s clear that Canada needs to be able to produce its own vaccines. It’s a matter of national security, and national health.

 

问题是，在目前疫苗缺货的紧急情况，特鲁多政府周二（2月2日）宣布的自产疫苗毫无意义。

 

But when it comes to addressing the current emergency, what the Trudeau government announced on Tuesday is meaningless.

 

位于蒙特利尔，属于加拿大国家研究委员会（NRC）的实验室将生产Novavax疫苗，但这要到今年12月才能建成并生产疫苗。它不能解决当前疫苗短缺的问题。它也无法为实现特鲁多的承诺，即在9月之前为每个想要打疫苗的加拿大人打上疫苗。

 

The National Research Council (NRC) lab in Montreal where the Novavax vaccine is to be made won’t be up and running until December. That’s too late to address the current shortage of vaccines. And it’s too late to help fulfill Mr. Trudeau’s promise to vaccinate every Canadian who wants a shot by September.

 

事实是，为了应对2021年的危机，特鲁多提出了2022年才能实施的应急方案。

 

In response to a crisis in 2021, Mr. Trudeau has put forward a plan for action in 2022.

 

比周二宣布自产疫苗更恶心的是，特鲁多政府曾经承诺，加拿大至少可以在去年年底自产一些疫苗。NRC去年表示，其蒙特利尔实验室下属的工厂将在今年7月全面投入运营。

 

And the PM’s Tuesday announcement was even more disingenuous than that. He ignored the fact that his government once promised to have at least some domestic vaccine production rolling in Canada by last December, and that the NRC said last year that its Montreal facility would be fully operational by July.

分享不同信息/观点，做明智判断/决策！请点击096.ca！

 

我们还纳闷，为何渥太华拒绝让蒙特利尔现有的一个私人企业生产疫苗。该企业的总裁说，若去年采取行动，他们可以很快生产疫苗。现在的问题是，特鲁多为什么要坚持在一个还没有完工的国家实验室生产疫苗？为什么拖到本月特鲁多才找到与该实验室合作生产疫苗的伙伴? 为何特鲁多尚未与其他疫苗制造商达成在加拿大生产疫苗的协议。

 

There have also been questions about why Ottawa declined to use an existing private manufacturing facility in Montreal, the president of which said last year could have been put into action quickly; why it insisted on going with a public lab that is still under construction; why it took until this month to find a partner to work with that lab; and why it has not reached licensing deals with other manufacturers to produce vaccines domestically.

 

现实是，渥太华的自产疫苗方案一点也不透明。我们可以肯定，要想从现在到9月底实现渥太华制定全民打疫苗的目标，周二(2月2日)特鲁多宣布的自产疫苗措施对实现此目标没有任何作用。

 

In fact, there has been no transparency about the government’s vaccine manufacturing strategy. All anyone can say for sure is that Tuesday’s announcement will have zero impact on the critical period between now and the end of September – which Ottawa needs to focus on.

 

2月2日至9月30日之间有240天。在这段时间内，每个加拿大人要打两次疫苗，这意味着加拿大每天需要配送30多万支疫苗。

 

There are 240 days between Feb. 2 and Sept. 30. To put two doses in every Canadian arm in that timeframe means the country will have to deliver more than 300,000 vaccines per day, every day.

 

 

上周，加拿大平均每天所打的疫苗不到两万支，由于辉瑞和莫德纳不能及时供货，这一速度可能会持续一段时间。更严峻的是，加拿大还没有批准其他疫苗的使用。

 

Last week, Canada averaged fewer than 20,000 vaccinations a day – a pace that will likely continue for some time, thanks to delayed deliveries from Pfizer and Moderna, and the fact no other vaccine has been approved here yet.

 

加拿大全民注射疫苗刚起步就出了大问题。特鲁多宣布加拿大在遥远的将来可能会自产疫苗，这纯粹是为了转移人们的视线。

 

The country’s early vaccination rollout is collapsing. Mr. Trudeau’s announcement about possible domestic production, in some very distant future, is nothing but a distraction.

 

 

编注：以上是加拿大全国发行的最大日报——《环球邮报》发表的社论。大中报编译。

 

Note: The Editorial was published by The Globe and Mail. Translated by Chinese News.